140 results
Page 2 of 7
8-K
EX-10.1
ab80njb6aufae cc
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
S-4
b5fwx llrbr476zp
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
S-4
xk97 6iugfz
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.1
dgim5
20 Dec 22
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-99.1
fbyjikvow0q10w0 zc
4 Aug 22
Adaptimmune Reports Second-Quarter Financial Results and Business Update
7:36am
8-K
8bsytxq6a793u
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-10.1
5kd69
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
424B5
4xm9bo0afl
28 Apr 22
Prospectus supplement for primary offering
8:09am
8-K
EX-10.01
puhkmdbgq31l7ukso7
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-10.2
vxqvbe
20 Aug 21
Entry into a Material Definitive Agreement
4:31pm